Published by Iain Gilbert on 6th November 2023
(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.
URL: http://www.digitallook.com/dl/news/story/33887251/...